Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
Fatani
Amal G
AG
Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Darweesh
Amal Q
AQ
Rizwan
Lubna
L
Aleisa
Abdulaziz M
AM
Al-Shabanah
Othman A
OA
Sayed-Ahmed
Mohamed M
MM
D000105:Acetyl Coenzyme A / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000633:toxicity*; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000473:pathology; D002331:Carnitine / Q000032:analysis / Q000172:deficiency* / Q000378:metabolism; D052279:Creatine Kinase, MB Form / Q000378:metabolism; D003520:Cyclophosphamide / Q000633:toxicity*; D004195:Disease Models, Animal; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008763:Methylhydrazines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012307:Risk Factors
D018906:Antineoplastic Agents, Alkylating; D008763:Methylhydrazines; D000105:Acetyl Coenzyme A; C050147:3-(2,2,2-trimethylhydrazine)propionate; D000255:Adenosine Triphosphate; D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase; D052279:Creatine Kinase, MB Form; D002331:Carnitine